Related Experiment Videos
Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial
S Barwood1, C Baillieu, R Boyd
1The Department of Orthopaedic Surgery, The Royal Children's Hospital, Parkville, Victoria, Australia.
Insights
Botulinum toxin A (BTX/A) injections effectively reduced postoperative pain and analgesic needs in children with spastic cerebral palsy (CP) undergoing adductor-release surgery. This treatment targets muscle spasms, offering a novel approach to pain management in CP patients.
Area of Science:
- Pediatric Orthopedics
- Neurology
- Pain Management
Background:
- Postoperative pain in children with spastic cerebral palsy (CP) is challenging, often linked to muscle spasms and poorly managed by traditional medications.
- Adductor-release surgery for hip dislocation in spastic CP patients frequently results in severe pain and muscle spasm.
Purpose of the Study:
- To evaluate the efficacy of preoperative botulinum toxin A (BTX/A) injections in reducing postoperative pain and analgesic requirements in children with spastic CP undergoing adductor-release surgery.
- To determine if BTX/A chemodenervation of surgical muscles can alleviate pain attributed to muscle spasm.
Main Methods:
- A double-blinded, randomized, placebo-controlled trial involving 16 pediatric patients (mean age 4.7 years) with spastic CP (diplegic or quadriplegic).
- Patients received either BTX/A intramuscular injections in target surgical muscles or a placebo before adductor-release surgery.
Main Results:
- BTX/A treatment resulted in a 74% reduction in mean pain scores compared to placebo (P<0.003).
- Patients receiving BTX/A required approximately 50% less analgesia (P<0.005) and had a 33% shorter hospital stay (P<0.003).
Conclusions:
- A significant component of postoperative pain in spastic CP patients undergoing adductor-release surgery is attributable to muscle spasm.
- Preoperative BTX/A injection is an effective strategy for managing this type of pain and may have broader applications for spasm-related pain.
Abstract:
Postoperative pain in children with spastic cerebral palsy (CP) is often attributed to muscle spasm and is difficult to manage using opiates and benzodiazepines. Adductor-release surgery to treat or prevent hip dislocation in children with spastic CP is frequently performed and is often accompanied by severe postoperative pain and spasm. A double-blinded, randomized, placebo-controlled clinical trial of 16 patients (mean age 4.7 years) with a mainly spastic type of CP (either diplegic or quadriplegic in distribution) was used to test the hypothesis that a significant proportion of postoperative pain is secondary to muscle spasm and, therefore, might be reduced by a preoperative chemodenervation of the target surgical muscle by intramuscular injection of botulinum toxin A (BTX/A). Compared with the placebo, BTX/A was found to be associated with a reduction in mean pain scores of 74% (P<0.003), a reduction in mean analgesic requirements of approximately 50% (P<0.005), and a reduction in mean length of hospital admission of 33% (P<0.003). It was concluded that an important component of postoperative pain in the patient population is due to muscle spasm and this can be managed effectively by preoperative injection with BTX/A. These findings may have implications for the management of pain secondary to muscle spasm in other clinical settings.